Biomarin Pharmaceutical (BMRN) Competitor Comparison
We are evaluating the key criteria listed to compare Biomarin Pharmaceutical (BMRN) against its competitors in the Biotechnology industry.
Market Capitalization
9 / 368Gross Profits
7 / 278Total Revenue
7 / 300EBITDA
12 / 337Free Cashflow
105 / 352Quick Ratio
310 / 357Earnings per Share
15 / 359Dividend yield
0 / 6Total Cash
18 / 358Performance 3 years
125 / 368Performance 5 years
141 / 368Performance 10 years
115 / 368Linearity 3 years
35 / 368Linearity 5 years
31 / 368Linearity 10 years
38 / 368Total Rank
17 / 368Dividend Rank
43 / 368Valuation Rank
93 / 368Piotroski Rank
1 / 368Muliplier Rank
294 / 368Market Capitalization - BMRN ranking 9 / 368
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.